Korean J Radiol.  2018 Aug;19(4):632-655. 10.3348/kjr.2018.19.4.632.

2017 Thyroid Radiofrequency Ablation Guideline: Korean Society of Thyroid Radiology

• Kim JH
• Baek JH
• Lim HK
• Ahn HS
• Baek SM
• Choi YJ
• Choi YJ
• Chung SR
• Ha EJ
• Hahn SY
• Jung SL
• Kim DS
• Kim SJ
• Kim YK
• Lee CY
• Lee JH
• Lee KH
• Lee YH
• Park JS
• Park H
• Shin JH
• Suh CH
• Sung JY
• Sim JS
• Youn I
• Choi M
• Na DG
• Guideline Committee for the Korean Society of Thyroid Radiology (KSThR) and Korean Society of Radiology

• KMID: 2413693
• DOI: http://doi.org/10.3348/kjr.2018.19.4.632

Abstract

Thermal ablation using radiofrequency is a new, minimally invasive modality employed as an alternative to surgery in patients with benign thyroid nodules and recurrent thyroid cancers. The Task Force Committee of the Korean Society of Thyroid Radiology (KSThR) developed recommendations for the optimal use of radiofrequency ablation for thyroid tumors in 2012. As new meaningful evidences have accumulated, KSThR decided to revise the guidelines. The revised guideline is based on a comprehensive analysis of the current literature and expert consensus.

Keyword

Thyroid; Ultrasound; Radiofrequency ablation; RF ablation; Thyroid recurrent cancers; Guideline

MeSH Terms

Advisory Committees
Catheter Ablation*
Consensus
Humans
Thyroid Gland*
Thyroid Neoplasms
Thyroid Nodule
Ultrasonography

Reference

1. Na DG, Lee JH, Jung SL, Kim JH, Sung JY, Shin JH, et al. Korean Society of Thyroid Radiology (KSThR). Korean Society of Radiology. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol. 2012; 13:117–125. PMID: 22438678.

2. Bandeira-Echtler E, Bergerhoff K, Richter B. Levothyroxine or minimally invasive therapies for benign thyroid nodules. Cochrane Database Syst Rev. 2014; CD004098. PMID: 24941398.

3. Mauri G, Cova L, Monaco CG, Sconfienza LM, Corbetta S, Benedini S, et al. Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA). Int J Hyperthermia. 2016; 11. 15. [Epub ahead of print]. DOI: 10.1080/02656736.2016.1244707.

4. Deandrea M, Limone P, Basso E, Mormile A, Ragazzoni F, Gamarra E, et al. US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules. Ultrasound Med Biol. 2008; 34:784–791. PMID: 18207307.

5. Jeong WK, Baek JH, Rhim H, Kim YS, Kwak MS, Jeong HJ, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol. 2008; 18:1244–1250. PMID: 18286289.

6. Kim YS, Rhim H, Tae K, Park DW, Kim ST. Radiofrequency ablation of benign cold thyroid nodules: initial clinical experience. Thyroid. 2006; 16:361–367. PMID: 16646682.

7. Spiezia S, Garberoglio R, Milone F, Ramundo V, Caiazzo C, Assanti AP, et al. Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation. Thyroid. 2009; 19:219–225. PMID: 19265492.

8. Baek JH, Jeong HJ, Kim YS, Kwak MS, Lee D. Radiofrequency ablation for an autonomously functioning thyroid nodule. Thyroid. 2008; 18:675–676. PMID: 18578625.

9. Baek JH, Kim YS, Lee D, Huh JY, Lee JH. Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. AJR Am J Roentgenol. 2010; 194:1137–1142. PMID: 20308523.

10. Lee JH, Kim YS, Lee D, Choi H, Yoo H, Baek JH. Radiofrequency ablation (RFA) of benign thyroid nodules in patients with incompletely resolved clinical problems after ethanol ablation (EA). World J Surg. 2010; 34:1488–1493. PMID: 20376445.

11. Sung JY, Kim YS, Choi H, Lee JH, Baek JH. Optimum first-line treatment technique for benign cystic thyroid nodules: ethanol ablation or radiofrequency ablation? AJR Am J Roentgenol. 2011; 196:W210–W214. PMID: 21257865.

12. Jung SL, Baek JH, Lee JH, Shong YK, Sung JY, Kim KS, et al. Efficacy and safety of radiofrequency ablation for benign thyroid nodules: a prospective multicenter study. Korean J Radiol. 2018; 19:167–174. PMID: 29354014.

13. Baek JH, Na DG, Lee JH, Jung SL, Sung JY, Sim JS. Korean society of thyroid radiology recommendations for radiofrequency ablation of thyroid nodules. Korean Society of Thyroid Radiology;2009. Accessed June 1, 2016. Available at: http://thyroidimaging.kr/.

14. Choi SJ, Jeong WK, Jo AJ, Choi JA, Kim MJ, Lee M, et al. Methodology for developing evidence-based clinical imaging guidelines: joint recommendations by Korean Society of Radiology and National Evidence-based Healthcare Collaborating Agency. Korean J Radiol. 2017; 18:208–216. PMID: 28096730.

15. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011; 155:529–536. PMID: 22007046.

16. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016; 26:1–133. PMID: 26462967.

17. Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013; 66:719–725. PMID: 23312392.

18. Jang SW, Baek JH, Kim JK, Sung JY, Choi H, Lim HK, et al. How to manage the patients with unsatisfactory results after ethanol ablation for thyroid nodules: role of radiofrequency ablation. Eur J Radiol. 2012; 81:905–910. PMID: 21388767.

19. Park HS, Baek JH, Na DG. Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA). Int J Hyperthermia. 2017; 33:953–954. PMID: 28540786.

20. Eng OS, Potdevin L, Davidov T, Lu SE, Chen C, Trooskin SZ. Does nodule size predict compressive symptoms in patients with thyroid nodules? Gland Surg. 2014; 3:232–236. PMID: 25493254.

21. Banks CA, Ayers CM, Hornig JD, Lentsch EJ, Day TA, Nguyen SA, et al. Thyroid disease and compressive symptoms. Laryngoscope. 2012; 122:13–16. PMID: 22147633.

22. Committee. IPA. Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules. Interventional procedures guidance [IPG562]. Web site. 2016. 6. Accessed Dec 1, 2016. https://www.nice.org.uk/Guidance/IPG562.

23. Shin JH, Baek JH, Chung J, Ha EJ, Kim JH, Lee YH, et al. Ultrasonography diagnosis and imaging-based management of thyroid nodules: revised Korean Society of Thyroid Radiology consensus statement and recommendations. Korean J Radiol. 2016; 17:370–395. PMID: 27134526.

24. Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedüs L, et al. AACE/ACE/AME Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules - 2016 update. Endocr Pract. 2016; 22:622–639. PMID: 27167915.

25. Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009; 19:1159–1165. PMID: 19888858.

26. Na DG, Baek JH, Jung SL, Kim JH, Sung JY, Kim KS, et al. Core needle biopsy of the thyroid: 2016 consensus statement and recommendations from Korean Society of Thyroid Radiology. Korean J Radiol. 2017; 18:217–237. PMID: 28096731.

27. Hong MJ, Na DG, Baek JH, Sung JY, Kim JH. Cytology-ultrasonography risk-stratification scoring system based on fine-needle aspiration cytology and the Korean-thyroid imaging reporting and data system. Thyroid. 2017; 27:953–959. PMID: 28463597.

28. McCoy KL, Jabbour N, Ogilvie JB, Ohori NP, Carty SE, Yim JH. The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size. Surgery. 2007; 142:837–844. discussion 844.e1-3. PMID: 18063065.

29. Mehanna R, Murphy M, McCarthy J, O'Leary G, Tuthill A, Murphy MS, et al. False negatives in thyroid cytology: impact of large nodule size and follicular variant of papillary carcinoma. Laryngoscope. 2013; 123:1305–1309. PMID: 23293053.

30. Agcaoglu O, Aksakal N, Ozcinar B, Sarici IS, Ercan G, Kucukyilmaz M, et al. Factors that affect the false-negative outcomes of fine-needle aspiration biopsy in thyroid nodules. Int J Endocrinol. 2013; 2013:126084. PMID: 23935616.

31. Giles WH, Maclellan RA, Gawande AA, Ruan DT, Alexander EK, Moore FD Jr, et al. False negative cytology in large thyroid nodules. Ann Surg Oncol. 2015; 22:152–157. PMID: 25074665.

32. Shin JJ, Caragacianu D, Randolph GW. Impact of thyroid nodule size on prevalence and post-test probability of malignancy: a systematic review. Laryngoscope. 2015; 125:263–272. PMID: 24965892.

33. Koo DH, Song K, Kwon H, Bae DS, Kim JH, Min HS, et al. Does tumor size influence the diagnostic accuracy of ultrasound-guided fine-needle aspiration cytology for thyroid nodules? Int J Endocrinol. 2016; 2016:3803647. PMID: 27774103.

34. Cavallo A, Johnson DN, White MG, Siddiqui S, Antic T, Mathew M, et al. Thyroid nodule size at ultrasound as a predictor of malignancy and final pathologic size. Thyroid. 2017; 27:641–650. PMID: 28052718.

35. Magister MJ, Chaikhoutdinov I, Schaefer E, Williams N, Saunders B, Goldenberg D. Association of thyroid nodule size and bethesda class with rate of malignant disease. JAMA Otolaryngol Head Neck Surg. 2015; 141:1089–1095. PMID: 26292176.

36. Kamran SC, Marqusee E, Kim MI, Frates MC, Ritner J, Peters H, et al. Thyroid nodule size and prediction of cancer. J Clin Endocrinol Metab. 2013; 98:564–570. PMID: 23275525.

37. Rossi ED, Bizzarro T, Fadda G, Pontecorvi A, Bernet V, Nassar A. The cytological diagnosis of a ‘benign thyroid lesion’: is it a real safe diagnosis for the patient. Cytopathology. 2016; 27:168–175. PMID: 26388423.

38. Kulstad R. Do all thyroid nodules> 4 cm need to be removed? An evaluation of thyroid fine-needle aspiration biopsy in large thyroid nodules. Endocr Pract. 2016; 22:791–798. PMID: 26919652.

39. Shi H, Bobanga I, McHenry CR. Are large thyroid nodules classified as benign on fine needle aspiration more likely to harbor cancer. Am J Surg. 2017; 213:464–466. PMID: 28057295.

40. Erdoğan MF, Kamel N, Aras D, Akdoğan A, Başkal N, Erdoğan G. Value of re-aspirations in benign nodular thyroid disease. Thyroid. 1998; 8:1087–1090. PMID: 9920362.

41. Chehade JM, Silverberg AB, Kim J, Case C, Mooradian AD. Role of repeated fine-needle aspiration of thyroid nodules with benign cytologic features. Endocr Pract. 2001; 7:237–243. PMID: 11497473.

42. Orlandi A, Puscar A, Capriata E, Fideleff H. Repeated fine-needle aspiration of the thyroid in benign nodular thyroid disease: critical evaluation of long-term follow-up. Thyroid. 2005; 15:274–278. PMID: 15785247.

43. Moon WJ, Jung SL, Lee JH, Na DG, Baek JH, Lee YH, et al. Thyroid Study Group. Korean Society of Neuro- and Head and Neck Radiology. Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study. Radiology. 2008; 247:762–770. PMID: 18403624.

44. Bonavita JA, Mayo J, Babb J, Bennett G, Oweity T, Macari M, et al. Pattern recognition of benign nodules at ultrasound of the thyroid: which nodules can be left alone? AJR Am J Roentgenol. 2009; 193:207–213. PMID: 19542415.

45. Kim JY, Jung SL, Kim MK, Kim TJ, Byun JY. Differentiation of benign and malignant thyroid nodules based on the proportion of sponge-like areas on ultrasonography: imaging-pathologic correlation. Ultrasonography. 2015; 34:304–311. PMID: 26006056.

46. Ahuja A, Chick W, King W, Metreweli C. Clinical significance of the comet-tail artifact in thyroid ultrasound. J Clin Ultrasound. 1996; 24:129–133. PMID: 8838301.

47. Beland MD, Kwon L, Delellis RA, Cronan JJ, Grant EG. Nonshadowing echogenic foci in thyroid nodules: are certain appearances enough to avoid thyroid biopsy? J Ultrasound Med. 2011; 30:753–760. PMID: 21632989.

48. Malhi H, Beland MD, Cen SY, Allgood E, Daley K, Martin SE, et al. Echogenic foci in thyroid nodules: significance of posterior acoustic artifacts. AJR Am J Roentgenol. 2014; 203:1310–1316. PMID: 25415710.

49. Lee ES, Kim JH, Na DG, Paeng JC, Min HS, Choi SH, et al. Hyperfunction thyroid nodules: their risk for becoming or being associated with thyroid cancers. Korean J Radiol. 2013; 14:643–652. PMID: 23901323.

50. Yoon RG, Baek JH, Lee JH, Choi YJ, Hong MJ, Song DE, et al. Diagnosis of thyroid follicular neoplasm: fine-needle aspiration versus core-needle biopsy. Thyroid. 2014; 24:1612–1617. PMID: 25089716.

51. Lee SH, Park GS, Jung SL, Kim MH, Bae JS, Lim DJ, et al. Core-needle biopsy for the preoperative diagnosis of follicular neoplasm in thyroid nodule screening: a validation study. Pathol Res Pract. 2016; 212:44–50.

52. Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016; 26:1343–1421. PMID: 27521067.

53. Sung JY, Baek JH, Jung SL, Kim JH, Kim KS, Lee D, et al. Radiofrequency ablation for autonomously functioning thyroid nodules: a multicenter study. Thyroid. 2015; 25:112–117. PMID: 25320840.

54. Baek JH, Moon WJ, Kim YS, Lee JH, Lee D. Radiofrequency ablation for the treatment of autonomously functioning thyroid nodules. World J Surg. 2009; 33:1971–1977. PMID: 19575141.

55. Faggiano A, Ramundo V, Assanti AP, Fonderico F, Macchia PE, Misso C, et al. Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study. J Clin Endocrinol Metab. 2012; 97:4439–4445. PMID: 23019349.

56. Bernardi S, Stacul F, Michelli A, Giudici F, Zuolo G, de Manzini N, et al. 12-month efficacy of a single radiofrequency ablation on autonomously functioning thyroid nodules. Endocrine. 2017; 57:402–408. PMID: 27848197.

57. Bernardi S, Dobrinja C, Fabris B, Bazzocchi G, Sabato N, Ulcigrai V, et al. Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules. Int J Endocrinol. 2014; 2014:934595. PMID: 25045352.

58. Che Y, Jin S, Shi C, Wang L, Zhang X, Li Y, et al. Treatment of benign thyroid nodules: comparison of surgery with radiofrequency ablation. AJNR Am J Neuroradiol. 2015; 36:1321–1325. PMID: 25814656.

59. Ugurlu MU, Uprak K, Akpinar IN, Attaallah W, Yegen C, Gulluoglu BM. Radiofrequency ablation of benign symptomatic thyroid nodules: prospective safety and efficacy study. World J Surg. 2015; 39:961–968. PMID: 25446486.

60. Garberoglio R, Aliberti C, Appetecchia M, Attard M, Boccuzzi G, Boraso F, et al. Radiofrequency ablation for thyroid nodules: which indications? The first Italian opinion statement. J Ultrasound. 2015; 18:423–430. PMID: 26550079.

61. Sandrock D, Olbricht T, Emrich D, Benker G, Reinwein D. Long-term follow-up in patients with autonomous thyroid adenoma. Acta Endocrinol (Copenh). 1993; 128:51–55. PMID: 8447194.

62. Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab. 1992; 75:714–720. PMID: 1517360.

63. Dupuy DE, Monchik JM, Decrea C, Pisharodi L. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery. 2001; 130:971–977. PMID: 11742325.

64. Baek JH, Kim YS, Sung JY, Choi H, Lee JH. Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. AJR Am J Roentgenol. 2011; 197:W331–W336. PMID: 21785061.

65. Guenette JP, Monchik JM, Dupuy DE. Image-guided ablation of postsurgical locoregional recurrence of biopsy-proven well-differentiated thyroid carcinoma. J Vasc Interv Radiol. 2013; 24:672–679. PMID: 23622038.

66. Long B, Li L, Yao L, Chen S, Yi H, Ye X, et al. Combined use of radioiodine therapy and radiofrequency ablation in treating postsurgical thyroid remnant of differentiated thyroid carcinoma. J Cancer Res Ther. 2015; 11:C244–C247. PMID: 26612446.

67. Monchik JM, Donatini G, Iannuccilli J, Dupuy DE. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg. 2006; 244:296–304. PMID: 16858194.

68. Park KW, Shin JH, Han BK, Ko EY, Chung JH. Inoperable symptomatic recurrent thyroid cancers: preliminary result of radiofrequency ablation. Ann Surg Oncol. 2011; 18:2564–2568. PMID: 21347777.

69. Zhao Q, Tian G, Kong D, Jiang T. Meta-analysis of radiofrequency ablation for treating the local recurrence of thyroid cancers. J Endocrinol Invest. 2016; 39:909–916. PMID: 26980591.

70. Suh CH, Baek JH, Choi YJ, Lee JH. Efficacy and safety of radiofrequency and ethanol ablation for treating locally recurrent thyroid cancer: a systematic review and meta-analysis. Thyroid. 2016; 26:420–428. PMID: 26782174.

71. Wang L, Ge M, Xu D, Chen L, Qian C, Shi K, et al. Ultrasonography-guided percutaneous radiofrequency ablation for cervical lymph node metastasis from thyroid carcinoma. J Cancer Res Ther. 2014; 10:C144–C149. PMID: 25450273.

72. Lee SJ, Jung SL, Kim BS, Ahn KJ, Choi HS, Lim DJ, et al. Radiofrequency ablation to treat loco-regional recurrence of well-differentiated thyroid carcinoma. Korean J Radiol. 2014; 15:817–826. PMID: 25469095.

73. Lim HK, Baek JH, Lee JH, Kim WB, Kim TY, Shong YK, et al. Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer. Eur Radiol. 2015; 25:163–170. PMID: 25199815.

74. Kim JH, Yoo WS, Park YJ, Park DJ, Yun TJ, Choi SH, et al. Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm. Radiology. 2015; 276:909–918. PMID: 25848897.

75. Zhang M, Luo Y, Zhang Y, Tang J. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid. 2016; 26:1581–1587. PMID: 27445090.

76. Kim JH, Baek JH, Sung JY, Min HS, Kim KW, Hah JH, et al. Radiofrequency ablation of low-risk small papillary thyroidcarcinoma: preliminary results for patients ineligible for surgery. Int J Hyperthermia. 2016; 9. 20. [Epub ahead of print]. DOI: 10.1080/02656736.2016.1230893.

77. Papini E, Guglielmi R, Gharib H, Misischi I, Graziano F, Chianelli M, et al. Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk. Thyroid. 2011; 21:917–920. PMID: 21595556.

78. Valcavi R, Piana S, Bortolan GS, Lai R, Barbieri V, Negro R. Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: a feasibility study on three cases with pathological and immunohistochemical evaluation. Thyroid. 2013; 23:1578–1582. PMID: 23978269.

79. Yue W, Wang S, Yu S, Wang B. Ultrasound-guided percutaneous microwave ablation of solitary T1N0M0 papillary thyroid microcarcinoma: initial experience. Int J Hyperthermia. 2014; 30:150–157. PMID: 24571178.

80. Lim HK, Baek SM, Baek JH. Us-guided RFA for primary thyroid cancer: efficacy and safety of long-term follow-up in a large population. In : CIRSE (Cardiovascular and Interventional Radiological Society of Europe); 2017 September 16-20; Copenhagen, Denmark:

81. Cakir B, Topaloglu O, Gul K, Agac T, Aydin C, Dirikoc A, et al. Ultrasound-guided percutaneous laser ablation treatment in inoperable aggressive course anaplastic thyroid carcinoma: the introduction of a novel alternative palliative therapy--second experience in the literature. J Endocrinol Invest. 2007; 30:624–625. PMID: 17848848.

82. Miyabayashi C, Ooiwa A, Katakura M, Ando T, Hasumoto Y, Terao Y, et al. [A successful treatment of percutaneous radio frequency ablation for advanced thyroid cancer]. Gan To Kagaku Ryoho. 2005; 32:1875–1877. PMID: 16315968.

83. Pacella CM, Bizzarri G, Spiezia S, Bianchini A, Guglielmi R, Crescenzi A, et al. Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology. 2004; 232:272–280. PMID: 15155898.

84. Owen RP, Silver CE, Ravikumar TS, Brook A, Bello J, Breining D. Techniques for radiofrequency ablation of head and neck tumors. Arch Otolaryngol Head Neck Surg. 2004; 130:52–56. PMID: 14732768.

85. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer. 1997; 79:564–573. PMID: 9028369.

86. Goldstein RE, Netterville JL, Burkey B, Johnson JE. Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules. Ann Surg. 2002; 235:656–662. discussion 662-664. PMID: 11981211.

87. Dosen D, Turic´ M, Smalcelj J, Janusic´ R, Grgic´ MP, Separovic´ V. The value of frozen section in intraoperative surgical management of thyroid follicular carcinoma. Head Neck. 2003; 25:521–528. PMID: 12808654.

88. Dabelic´ N, Matesa N, Matesa-Anic´ D, Kusic´ Z. Malignancy risk assessment in adenomatoid nodules and suspicious follicular lesions of the thyroid obtained by fine needle aspiration cytology. Coll Antropol. 2010; 34:349–354. PMID: 20698101.

89. Deveci MS, Deveci G, LiVolsi VA, Baloch ZW. Fine-needle aspiration of follicular lesions of the thyroid. Diagnosis and follow-Up. Cytojournal. 2006; 3:9. PMID: 16603062.

90. Song YS, Kim JH, Na DG, Min HS, Won JK, Yun TJ, et al. Ultrasonographic differentiation between nodular hyperplasia and neoplastic follicular-patterned lesions of the thyroid gland. Ultrasound Med Biol. 2016; 42:1816–1824. PMID: 27166018.

91. Choi YJ, Yun JS, Kim DH. Clinical and ultrasound features of cytology diagnosed follicular neoplasm. Endocr J. 2009; 56:383–389. PMID: 19164864.

92. Baek JH, Lee JH, Valcavi R, Pacella CM, Rhim H, Na DG. Thermal ablation for benign thyroid nodules: radiofrequency and laser. Korean J Radiol. 2011; 12:525–540. PMID: 21927553.

93. Chung SR, Suh CH, Baek JH, Park HS, Choi YJ, Lee JH. Safety of radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: a systematic review and meta-analysis. Int J Hyperthermia. 2017; 33:920–930. PMID: 28565997.

94. Sim JS, Baek JH, Lee J, Cho W, Jung SI. Radiofrequency ablation of benign thyroid nodules: depicting early sign of regrowth by calculating vital volume. Int J Hyperthermia. 2017; 33:905–910. PMID: 28540795.

95. Ha SM, Sung JY, Baek JH, Na DG, Kim JH, Yoo H, et al. Radiofrequency ablation of small follicular neoplasms: initial clinical outcomes. Int J Hyperthermia. 2017; 33:931–937. PMID: 28545338.

96. Dobrinja C, Bernardi S, Fabris B, Eramo R, Makovac P, Bazzocchi G, et al. Surgical and pathological changes after radiofrequency ablation of thyroid nodules. Int J Endocrinol. 2015; 2015:576576. PMID: 26265914.

97. Hahn SY, Shin JH, Oh YL. What is the ideal core number for ultrasonography-guided thyroid biopsy of cytologically inconclusive nodules? AJNR Am J Neuroradiol. 2017; 38:777–781. PMID: 28154123.

98. Kwak JY, Koo H, Youk JH, Kim MJ, Moon HJ, Son EJ, et al. Value of US correlation of a thyroid nodule with initially benign cytologic results. Radiology. 2010; 254:292–300. PMID: 20019136.

99. Ahn HS, Kim SJ, Park SH, Seo M. Radiofrequency ablation of benign thyroid nodules: evaluation of the treatment efficacy using ultrasonography. Ultrasonography. 2016; 35:244–252. PMID: 27101983.

100. Baek JH, Lee JH, Sung JY, Bae JI, Kim KT, Sim J, et al. Korean Society of Thyroid Radiology. Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: a multicenter study. Radiology. 2012; 262:335–342. PMID: 21998044.

101. Hong MJ, Baek JH, Choi YJ, Lee JH, Lim HK, Shong YK, et al. Radiofrequency ablation is a thyroid function-preserving treatment for patients with bilateral benign thyroid nodules. J Vasc Interv Radiol. 2015; 26:55–61. PMID: 25446422.

102. Ha EJ, Baek JH, Lee JH, Sung JY, Lee D, Kim JK, et al. Radiofrequency ablation of benign thyroid nodules does not affect thyroid function in patients with previous lobectomy. Thyroid. 2013; 23:289–293. PMID: 23013110.

103. Torres MR, Nóbrega Neto SH, Rosas RJ, Martins AL, Ramos AL, da Cruz TR. Thyroglobulin in the washout fluid of lymph-node biopsy: what is its role in the follow-up of differentiated thyroid carcinoma? Thyroid. 2014; 24:7–18. PMID: 24044517.

104. Rosario PW, Carvalho M, Mourão GF, Calsolari MR. Comparison of antithyroglobulin antibody concentrations before and after ablation with 131i as a predictor of structural disease in differentiated thyroid carcinoma patients with undetectable basal thyroglobulin and negative neck ultrasonography. Thyroid. 2016; 26:525–531. PMID: 26831821.

105. Jeon SJ, Kim E, Park JS, Son KR, Baek JH, Kim YS, et al. Diagnostic benefit of thyroglobulin measurement in fine-needle aspiration for diagnosing metastatic cervical lymph nodes from papillary thyroid cancer: correlations with US features. Korean J Radiol. 2009; 10:106–111. PMID: 19270855.

106. Kwok A, Faigel DO. Management of anticoagulation before and after gastrointestinal endoscopy. Am J Gastroenterol. 2009; 104:3085–3097. quiz 3098. PMID: 19672250.

107. Baek JH, Ha EJ, Choi YJ, Sung JY, Kim JK, Shong YK. Radiofrequency versus ethanol ablation for treating predominantly cystic thyroid nodules: a randomized clinical trial. Korean J Radiol. 2015; 16:1332–1340. PMID: 26576124.

108. Park HS, Baek JH, Park AW, Chung SR, Choi YJ, Lee JH. Thyroid radiofrequency ablation: updates on innovative devices and techniques. Korean J Radiol. 2017; 18:615–623. PMID: 28670156.

109. Bernardi S, Lanzilotti V, Papa G, Panizzo N, Dobrinja C, Fabris B, et al. Full-thickness skin burn caused by radiofrequency ablation of a benign thyroid nodule. Thyroid. 2016; 26:183–184. PMID: 26561213.

110. Huh JY, Baek JH, Choi H, Kim JK, Lee JH. Symptomatic benign thyroid nodules: efficacy of additional radiofrequency ablation treatment session--prospective randomized study. Radiology. 2012; 263:909–916. PMID: 22438360.

111. Ha EJ, Baek JH, Lee JH. Moving-shot versus fixed electrode techniques for radiofrequency ablation: comparison in an ex-vivo bovine liver tissue model. Korean J Radiol. 2014; 15:836–843. PMID: 25469097.

112. Ha EJ, Baek JH, Lee JH. Ultrasonography-based thyroidal and perithyroidal anatomy and its clinical significance. Korean J Radiol. 2015; 16:749–766. PMID: 26175574.

113. Shin JH, Baek JH, Ha EJ, Lee JH. Radiofrequency ablation of thyroid nodules: basic principles and clinical application. Int J Endocrinol. 2012; 2012:919650. PMID: 23133449.

114. Laeseke PF, Sampson LA, Brace CL, Winter TC 3rd, Fine JP, Lee FT Jr. Unintended thermal injuries from radiofrequency ablation: protection with 5% dextrose in water. AJR Am J Roentgenol. 2006; 186(5 Suppl):S249–S254. PMID: 16632684.

115. Kohlhase KD, Korkusuz Y, Gröner D, Erbelding C, Happel C, Luboldt W, et al. Bipolar radiofrequency ablation of benign thyroid nodules using a multiple overlapping shot technique in a 3-month follow-up. Int J Hyperthermia. 2016; 32:511–516. PMID: 27126512.

116. Lim HK, Lee JH, Ha EJ, Sung JY, Kim JK, Baek JH. Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients. Eur Radiol. 2013; 23:1044–1049. PMID: 23096937.

117. Cesareo R, Pasqualini V, Simeoni C, Sacchi M, Saralli E, Campagna G, et al. Prospective study of effectiveness of ultrasound-guided radiofrequency ablation versus control group in patients affected by benign thyroid nodules. J Clin Endocrinol Metab. 2015; 100:460–466. PMID: 25387256.

118. Baek JH. Radiofrequency ablation of thyroid and parathyroid nodules. In : Clark T, Sabharwal T, editors. Interventional radiology techniques in ablation. 1st ed. London: Springer;2013. p. 53–72.

119. Brunese L, Romeo A, Iorio S, Napolitano G, Fucili S, Zeppa P, et al. Thyroid B-flow twinkling sign: a new feature of papillary cancer. Eur J Endocrinol. 2008; 159:447–451. PMID: 18644823.

120. Zhao CK, Xu HX, Lu F, Sun LP, He YP, Guo LH, et al. Factors associated with initial incomplete ablation for benign thyroid nodules after radiofrequency ablation: first results of CEUS evaluation. Clin Hemorheol Microcirc. 2017; 65:393–405. PMID: 27983547.

121. Tang X, Cui D, Chi J, Wang Z, Wang T, Zhai B, et al. Evaluation of the safety and efficacy of radiofrequency ablation for treating benign thyroid nodules. J Cancer. 2017; 8:754–760. PMID: 28382137.

122. Spencer CA. Clinical review: clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab. 2011; 96:3615–3627. PMID: 21917876.

123. Papini E, Bizzarri G, Bianchini A, Valle D, Misischi I, Guglielmi R, et al. Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer. J Clin Endocrinol Metab. 2013; 98:E92–E97. PMID: 23150695.

124. Zhou W, Zhang L, Zhan W, Jiang S, Zhu Y, Xu S. Percutaneous laser ablation for treatment of locally recurrent papillary thyroid carcinoma <15 mm. Clin Radiol. 2016; 71:1233–1239. PMID: 27554615.

125. Aysan E, Idiz UO, Akbulut H, Elmas L. Single-session radiofrequency ablation on benign thyroid nodules: a prospective single center study: radiofrequency ablation on thyroid. Langenbecks Arch Surg. 2016; 401:357–363. PMID: 27013327.

126. Baek JH, Jeong HJ, Kim YS, Kwak MS, Rhim HC, Chang SH. Percutaneous radiofrequency ablation for benign nodules of the thyroid gland. J Korean Radiol Soc. 2005; 52:379–384.

127. Li XL, Xu HX, Lu F, Yue WW, Sun LP, Bo XW, et al. Treatment efficacy and safety of ultrasound-guided percutaneous bipolar radiofrequency ablation for benign thyroid nodules. Br J Radiol. 2016; 89:20150858. PMID: 26800232.

128. Sung JY, Baek JH, Kim KS, Lee D, Yoo H, Kim JK, et al. Single-session treatment of benign cystic thyroid nodules with ethanol versus radiofrequency ablation: a prospective randomized study. Radiology. 2013; 269:293–300. PMID: 23616630.

129. Kim TH, Kim SM, Jung AL, Moon SK, Yang DH, Park CM, et al. Efficacy and safety of radiofrequency ablation performed by an endocrinologist for benign thyroid nodules. Int J Thyroidol. 2015; 8:183–186.

130. Valcavi R, Tsamatropoulos P. Health-related quality of life after percutaneous radiofrequency ablation of cold, solid, benign thyroid nodules: a 2-year follow-up study in 40 patients. Endocr Pract. 2015; 21:887–896. PMID: 26121459.

131. Yue WW, Wang SR, Lu F, Sun LP, Guo LH, Zhang YL, et al. Radiofrequency ablation vs. microwave ablation for patients with benign thyroid nodules: a propensity score matching study. Endocrine. 2017; 55:485–495. PMID: 27905049.

132. Deandrea M, Sung JY, Limone P, Mormile A, Garino F, Ragazzoni F, et al. Efficacy and safety of radiofrequency ablation versus observation for nonfunctioning benign thyroid nodules: a randomized controlled international collaborative trial. Thyroid. 2015; 25:890–896. PMID: 26061686.

133. Suh CH, Baek JH, Ha EJ, Choi YJ, Lee JH, Kim JK, et al. Ethanol ablation of predominantly cystic thyroid nodules: evaluation of recurrence rate and factors related to recurrence. Clin Radiol. 2015; 70:42–47. PMID: 25443776.

134. Park HS, Baek JH, Choi YJ, Lee JH. Innovative techniques for image-guided ablation of benign thyroid nodules: combined ethanol and radiofrequency ablation. Korean J Radiol. 2017; 18:461–469. PMID: 28458598.

135. Kim DW. Sonography-guided ethanol ablation of a remnant solid component after radio-frequency ablation of benign solid thyroid nodules: a preliminary study. AJNR Am J Neuroradiol. 2012; 33:1139–1143. PMID: 22268084.

136. Yoon HM, Baek JH, Lee JH, Ha EJ, Kim JK, Yoon JH, et al. Combination therapy consisting of ethanol and radiofrequency ablation for predominantly cystic thyroid nodules. AJNR Am J Neuroradiol. 2014; 35:582–586. PMID: 23969340.

137. Ha EJ, Baek JH, Kim KW, Pyo J, Lee JH, Baek SH, et al. Comparative efficacy of radiofrequency and laser ablation for the treatment of benign thyroid nodules: systematic review including traditional pooling and bayesian network meta-analysis. J Clin Endocrinol Metab. 2015; 100:1903–1911. PMID: 25695887.

138. Fuller CW, Nguyen SA, Lohia S, Gillespie MB. Radiofrequency ablation for treatment of benign thyroid nodules: systematic review. Laryngoscope. 2014; 124:346–353. PMID: 24122763.

139. Chen F, Tian G, Kong D, Zhong L, Jiang T. Radiofrequency ablation for treatment of benign thyroid nodules: a PRISMA-compliant systematic review and meta-analysis of outcomes. Medicine (Baltimore. Medicine (Baltimore). 2016; 95:e465.

140. Hegedüs L. Clinical practice. The thyroid nodule. N Engl J Med. 2004; 351:1764–1177. PMID: 15496625.

141. Døssing H, Bennedbaek FN, Bonnema SJ, Grupe P, Hegedüs L. Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules. Eur J Endocrinol. 2007; 157:95–100. PMID: 17609407.

142. Chianelli M, Bizzarri G, Todino V, Misischi I, Bianchini A, Graziano F, et al. Radiofrequency ablation for treatment of benign thyroid nodules: a PRISMA-compliant systematic review and meta-analysis of outcomes. J Clin Endocrinol Metab. 2014; 99:E1283–E1286. PMID: 24684455.

143. Ha EJ, Baek JH, Lee JH. The efficacy and complications of radiofrequency ablation of thyroid nodules. Curr Opin Endocrinol Diabetes Obes. 2011; 18:310–314. PMID: 21841482.

144. Kim C, Lee JH, Choi YJ, Kim WB, Sung TY, Baek JH. Complications encountered in ultrasonography-guided radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers. Eur Radiol. 2017; 27:3128–3137. PMID: 27975148.

145. Wang JF, Wu T, Hu KP, Xu W, Zheng BW, Tong G, et al. Complications following radiofrequency ablation of benign thyroid nodules: a systematic review. Chin Med J (Engl). 2017; 130:1361–1370. PMID: 28524837.

146. Ha EJ, Baek JH, Lee JH, Kim JK, Shong YK. Clinical significance of vagus nerve variation in radiofrequency ablation of thyroid nodules. Eur Radiol. 2011; 21:2151–2157. PMID: 21633824.

147. Shin JE, Baek JH, Ha EJ, Choi YJ, Choi WJ, Lee JH. Ultrasound features of middle cervical sympathetic ganglion. Clin J Pain. 2015; 31:909–913. PMID: 25411859.

148. Bernardi S, Stacul F, Zecchin M, Dobrinja C, Zanconati F, Fabris B. Radiofrequency ablation for benign thyroid nodules. J Endocrinol Invest. 2016; 39:1003–1013. PMID: 27098804.

149. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003; 226:441–451. PMID: 12563138.

150. Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002; 89:1206–1222. PMID: 12296886.

151. Korkusuz Y, Erbelding C, Kohlhase K, Luboldt W, Happel C, Grünwald F. Bipolar radiofrequency ablation of benign symptomatic thyroid nodules: initial experience. Rofo. 2016; 188:671–675. PMID: 26713416.

152. Branovan DI, Fridman M, Lushchyk M, Drozd V, Krasko O, Nedzvedz O, et al. Morphological changes induced by bipolar radiofrequency ablation in thyroid nodules - a preclinical ex vivo investigation. Eur Endocrinol. 2016; 12:85–88. PMID: 29632593.

153. Yue WW, Li XL, Xu HX, Lu F, Sun LP, Guo LH, et al. Quality of life and cost-effectiveness of radiofrequency ablation versus open surgery for benign thyroid nodules: a retrospective cohort study. Sci Rep. 2016; 6:37838. PMID: 27883069.